化合物详情
CAS21919-05-1
分子式C9H8N4O5
分子量252.18 g/mol
非危品
Tretazicar is under investigation in clinical trial NCT00746590 (Study of Anti-tumour Effects and Safety of Prolarix™ in Hepatocellular Carcinoma).
科学粮草官-词典编辑部,修订于:2026-07-06

Structures
StructuresSMILES
C1CN1C2=C(C=C(C(=C2)C(=O)N)[N+](=O)[O-])[N+](=O)[O-]





